SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-118431
Filing Date
2015-04-03
Accepted
2015-04-03 06:07:38
Documents
5
Period of Report
2015-05-26
Effectiveness Date
2015-04-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d898478ddef14a.htm DEF 14A 606117
2 GRAPHIC g898478g71o10.jpg GRAPHIC 20657
3 GRAPHIC g898478g92z65.jpg GRAPHIC 7243
4 GRAPHIC g898478pc_pg001.jpg GRAPHIC 134408
5 GRAPHIC g898478pc_pg002.jpg GRAPHIC 94444
  Complete submission text file 0001193125-15-118431.txt   961543
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32979 | Film No.: 15750153
SIC: 2834 Pharmaceutical Preparations